Skip to the page

Data / Form D filings / Neuronex, Inc.

Neuronex, Inc.: Form D filings

Neuronex, Inc., a pharmaceuticals company in Morrisville, NC, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on May 6, 2011, reports $399,999 sold of a $1.2 million offering to 6 investors.

Find out what Neuronex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9001 AERIAL CENTER PARKWAY, SUITE 110, Morrisville, NC, 27560
Phone
(919) 460-9500
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2010
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1500840

The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 6, 2011New notice$1,200,000$399,999$800,0016Apr 15, 2011sec.gov
Sep 8, 2010New notice$1,450,000$849,999$600,0012Aug 31, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Moise KhayrallahExecutive Officer, Director
Gary BreamExecutive Officer
Stephen ButtsExecutive Officer
Clayton DuncanExecutive Officer

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of May 2, 2011 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Neuronex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.